Concepedia

Author

Heather Sweet

Amgen (United States)ORCID

Also Known As

H Sweet, H.L. Sweet, Heather Sweet

12

Publications

481

Citations

7

H-Index

28

Concepts

All Affiliations

Amgen (United States)Amgen (Canada)
HS

About

Heather Sweet is an author at Amgen (United States) specializing in medicine, immunology, and immunoengineering.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

4

4

153

2

Engineering

1

1

279

3

Biochemistry

1

1

15

4

Biomedical Engineering

1

1

279

5

Biomolecular Engineering

1

1

279

Heather Sweet

×

7

Publications

473

Citations

7

H-Index

YearCitations

Enhancing Antibody Fc Heterodimer Formation through Electrostatic Steering Effects

Kannan Gunasekaran, Martin Pentony, Min Shen,

Journal of Biological Chemistry

2010

279

Asymmetrical Fc Engineering Greatly Enhances Antibody-dependent Cellular Cytotoxicity (ADCC) Effector Function and Stability of the Modified Antibodies

Zhi Liu, Kannan Gunasekaran, Wei Wang,

Journal of Biological Chemistry

2013

72

Priming of CD8+ CTL effector cells in mice by immunization with a stress protein–influenza virus nucleoprotein fusion molecule

Lawrence S.D. Anthony, Huacheng Wu, Heather Sweet,

Vaccine

1999

47

Antitumor activity of motesanib alone and in combination with cisplatin or docetaxel in multiple human non–small-cell lung cancer xenograft models

Angela Coxon, Beth Ziegler, Stephen A. Kaufman,

Molecular Cancer

2012

24

Preferential extravasation and accumulation of liposomal vincristine in tumor comparing to normal tissue enhances antitumor activity

Siqing Shan, Clay Flowers, Cathy D. Peltz,

Cancer Chemotherapy and Pharmacology

2005

19

Functional and Nonclinical Similarity of ABP 980, a Biosimilar of Trastuzumab

Shea Jassem, Wei Wang, Heather Sweet,

Pharmaceutical Research

2019

17

Analytical and functional similarity of biosimilar ABP 798 with rituximab reference product

Neung‐Seon Seo, Zhe Huang, Scott Kuhns,

Biologicals

2020

15

Page 1